한국여성에서 조직 미네랄 농도에 따른 생리전증후군의 임상증상 = Clinical symptom of premenstrual syndrome in Korean women acorrding to tissue mineral concentration

다국어 초록 (Multilingual Abstract)

Objective: Premenstrual syndrome (PMS) is a disease with specific psychologic and physical symptoms on luteal phase. Its incidence is variable in 20~80%, but its cause is not definitely proved. Because progesterone and estrogen affect the balance of the body mineral, the alteration of progestorone and estrogen in the patients with PMS may effect the imbalance of tissue mineral, that can induce the specific symptoms of PMS. This study examines the relationship between symptoms of PMS and mineral count by tissue mineral test. Methods: Women who volunteered for the tissue mineral test completed MMDQ questionnaire and checked blood test for Ca, Mg, Na, K, Cu, Zn. The tissue mineral test used the hair not treated within 3 weeks and not washed within 3 hours. The hair was send to TEI for the analysis. We used SPSS (14.0) for statistical analysis. Results: The MMDQ score of the normal Mg group is significantly higher than the high Mg group (22.5±17.8 vs. 13.9±11.1), and the behavioral disorder score of the normal Na group is significantly lower than the low Na group (2.2±1.7 vs. 3.4±2.2). The MMDQ score of the normal Cu group is significantly lower than abnormal group (15.7±11.9 vs. 24.9±16.9). Conclusions: Total score of MMDQ showed difference according to magnesium and copper concentrations in tissue, and scores of behavioral disorder was affected by sodium concentration of tissue. Additional study about cause and effect relationship is required.

참고문헌 (Reference)

1 조현희, "생리전증후군 환자에서 식이 습관과 조직미네랄의 특징" 50 : 666-672, 2007

2 Levenson CW, "the new antidepressant" 64 : 39-42, 2006

3 Tonini G, "endometriosis and premenstrual syndrome" 54 : 525-538, 2002

4 Chuong CJ, "Zinc and copper levels in premenstrual syndrome" 62 : 313-320, 1994

5 David LW, "Trace elements and other essential nutrients" 84-, 1995

6 Greene R, "The premenstural syndrome" 1 : 1007-1014, 1953

7 Greene R, "The premenstural syndrome" 1 : 1007-1014, 1953

8 Rees L, "The premenstrual tension syndrome and its treatment" 1 : 1014-1016, 1953

9 Bendich A, "The potential for dietary supplements to reduce premenstrual syndrome symptoms" 19 : 3-12, 2000

10 Collin D, "The corpus luteum and progesterone secretion" 86 : 563-565, 1991

11 Kouri EM, "State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes" 33 : 767-770, 1997

12 Steele PA, "Regulation of pulsatilesecretion of progesterone during the human luteal phase" 4 : 117-124, 1986

13 Wittchen HU, "Prevalence, incidence and stability of premenstrual dysphoric disorder in the community" 32 : 119-132, 2002

14 Freeman EW, "Premenstrual syndrome: current perspectives on treatment and etiology" 9 : 147-153, 1997

15 Domoney CL, "Premenstrual syndrome and the use of alternative therapies" 997 : 330-340, 2003

16 Gianetto-Berruti A, "Premenstrual syndrome" 54 : 85-95, 2002

17 Campbell EM, "Premenstrual symptoms in general practice patients. Prevalence and treatment" 42 : 637-646, 1997

18 Elliott H, "Premenstrual dysphoric disorder. a guide for the treating clinician" 63 : 72-75, 2002

19 Seipple L, "Physical symptoms in premenstrual syndrome are related to plasma progesterone and dexosycorticosterone" 14 : 173-181, 2000

20 Facchinetti F, "Oral magnesium successfully relieves premenstrual mood changes" 78 : 177-181, 1991

21 Enomoto T, "Neuroprotective effects of magnesium on cerebral ischemia and cerebral contusion" 14 : 60-64, 2004

22 Shiekhattar R, "NMDA-receptor- mediated sensory responses of brain noradrenergic neurons are suppressed by in vivo concentrations of extracelluar magnesium" 10 : 103-109, 1992

23 Thys-Jacobs S, "Micronutrients and the premenstural syndrome: the case for calcium" 19 : 220-227, 2000

24 Rosenstein DL, "Magnesium measures across the menstrual cycle in premenstrual syndrome" 35 : 557-561, 1994

25 Papadopol V, "Magnesium and some psychological features in two groups of pubils" 14 : 27-32, 2001

26 Johnson SR, "Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help- seeking behavior" 33 : 340-346, 1988

27 Oelkers W, "Effects of progesterone and four synthetic progestogens on sodium balance and the renin aldosterone system in man" 39 : 882-890, 1974

28 Redei E, "Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms" 20 : 259-267, 1995

29 Rubinow DR, "Changes in plasmahormonesacrossthemenstrualcycle in patients with menstrually related mood disorder and in control subjects" 158 : 5-11, 1988

30 Williams RJ, "Biochemical individuality : the basis for genetotrophic concept" Keats publishing 1998

31 Chakmakjian ZH, "Bioavailability of progesterone with different modes of administration" 32 : 443-448, 1987

32 Lombaridi I, "Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstural syndrome" 18 : 79-87, 2004

33 Menkes DB, "Acute tryptophan depletion aggravates premenstrual syndrome" 32 : 37-44, 1994